| iQone Healthcare Switzerland SA - Osenvelt 120 mg/1.7 ml (70 mg/ml), solution injectable |
| 70196 | | 01 | | Osenvelt 120 mg/1.7 ml (70 mg/ml) | | solution injectable | | M05BX04 | | Denosumab | | 19.08.2025 | | |
|
| Composition |
| denosumabum 120 mg, acidum aceticum glaciale, natrii acetas trihydricus corresp. natrium 0.5 mg, sorbitolum 79.9 mg, polysorbatum 20, aqua ad iniectabile ad solutionem pro 1.7 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Denosumabum | 120mg / 1.7ml |
| | BAG: Principe actif | Concentr. |
|---|
| Denosumabum | 120 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Aceticum Glaciale | | | Natrii Acetas Trihydricus | | | Polysorbatum 20 | | | Sorbitol | 79.9mg / 1.7ml |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | 284.86 | 326.20 | A | LS | Non |
|
